These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29230744)

  • 1. [Breast cancer in male].
    Würstlein R; Hesse A; König A; Schulte-Vorwick F; Schrodi S; Ditsch N; Mahner S; Harbeck N
    MMW Fortschr Med; 2017 Dec; 159(21-22):67-72. PubMed ID: 29230744
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis.
    Gargiulo P; Pensabene M; Milano M; Arpino G; Giuliano M; Forestieri V; Condello C; Lauria R; De Placido S
    BMC Cancer; 2016 Jul; 16():375. PubMed ID: 27377827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to "Male Patients With Breast Cancer: Addressing Needs Using an Educational Task Force".
    Mahon SM; Nagtalon Cutrone J; Baron RH
    Clin J Oncol Nurs; 2018 Dec; 22(6):610. PubMed ID: 30452015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Guys Don't Have Breasts": The Lived Experience of Men Who Have BRCA Gene Mutations and Are at Risk for Male Breast Cancer.
    Skop M; Lorentz J; Jassi M; Vesprini D; Einstein G
    Am J Mens Health; 2018 Jul; 12(4):961-972. PubMed ID: 29400121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.
    de Juan I; Palanca S; Domenech A; Feliubadaló L; Segura Á; Osorio A; Chirivella I; de la Hoya M; Sánchez AB; Infante M; Tena I; Díez O; Garcia-Casado Z; Vega A; Teulé À; Barroso A; Pérez P; Durán M; Carrasco E; Juan-Fita MJ; Murria R; Llop M; Barragan E; Izquierdo Á; Benítez J; Caldés T; Salas D; Bolufer P
    Fam Cancer; 2015 Dec; 14(4):505-13. PubMed ID: 26026974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1/2 mutation analysis in male breast cancer families from North West England.
    Evans DG; Bulman M; Young K; Howard E; Bayliss S; Wallace A; Lalloo F
    Fam Cancer; 2008; 7(2):113-7. PubMed ID: 17636422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Male BRCA mutation carriers: clinical characteristics and cancer spectrum.
    Ibrahim M; Yadav S; Ogunleye F; Zakalik D
    BMC Cancer; 2018 Feb; 18(1):179. PubMed ID: 29433453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer in Morocco: a literature review.
    Slaoui M; Razine R; Ibrahimi A; Attaleb M; Mzibri ME; Amrani M
    Asian Pac J Cancer Prev; 2014; 15(3):1067-74. PubMed ID: 24606420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer surgery trend changes since the introduction of BRCA1/2 mutation screening: a retrospective cohort analysis of 158 mutation carriers treated at a single institution.
    Mislowsky A; Domchek S; Stroede C; Bergey MR; Sonnad SS; Wu L; Tchou J
    Ann Surg Oncol; 2011 Mar; 18(3):745-51. PubMed ID: 20972632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
    Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
    Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and morphological features of breast cancer in men].
    Nikolaev KS
    Vopr Onkol; 2013; 59(3):358-62. PubMed ID: 23909038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Penetrance of BRCA1 and BRCA2 Germline Mutations in Colombian Breast Cancer Patients.
    Torres D; Bermejo JL; Rashid MU; Briceño I; Gil F; Beltran A; Ariza V; Hamann U
    Sci Rep; 2017 Jul; 7(1):4713. PubMed ID: 28680148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of 54-year-old man with breast cancer after prolonged testosterone therapy.
    Krause W
    Clin Adv Hematol Oncol; 2005 Sep; 3(9):714. PubMed ID: 16224446
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients.
    Rashid MU; Zaidi A; Torres D; Sultan F; Benner A; Naqvi B; Shakoori AR; Seidel-Renkert A; Farooq H; Narod S; Amin A; Hamann U
    Int J Cancer; 2006 Dec; 119(12):2832-9. PubMed ID: 16998791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study.
    Giannakeas V; Lubinski J; Gronwald J; Moller P; Armel S; Lynch HT; Foulkes WD; Kim-Sing C; Singer C; Neuhausen SL; Friedman E; Tung N; Senter L; Sun P; Narod SA
    Breast Cancer Res Treat; 2014 Aug; 147(1):113-8. PubMed ID: 25082516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unexpectedly low frequency of BRCA1/2 deleterious mutations in Japanese patients with breast cancer.
    Sakamoto I; Nakagomi H; Okimoto K; Inoue M; Hirotsu Y; Amemiya K; Mochizuki H; Omata M
    Breast J; 2018 Jan; 24(1):96-98. PubMed ID: 28597494
    [No Abstract]   [Full Text] [Related]  

  • 17. Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families.
    Stadler ZK; Saloustros E; Hansen NA; Schluger AE; Kauff ND; Offit K; Robson ME
    Breast Cancer Res Treat; 2010 Sep; 123(2):581-5. PubMed ID: 20221693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer.
    Fostira F; Saloustros E; Apostolou P; Vagena A; Kalfakakou D; Mauri D; Tryfonopoulos D; Georgoulias V; Yannoukakos D; Fountzilas G; Konstantopoulou I
    Breast Cancer Res Treat; 2018 May; 169(1):105-113. PubMed ID: 29335925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 and BRCA2 in Indian breast cancer patients.
    Saxena S; Szabo CI; Chopin S; Barjhoux L; Sinilnikova O; Lenoir G; Goldgar DE; Bhatanager D
    Hum Mutat; 2002 Dec; 20(6):473-4. PubMed ID: 12442273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer.
    Narod SA
    Breast Cancer Res Treat; 2011 Jul; 128(2):581-3. PubMed ID: 21455666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.